[CLINICAL EVALUATION OF VISOTRAST, A NEW TRIIODINATED ROENTGEN CONTRAST MEDIUM OF THE AMIDOTRIZOATE TYPE].
D000790:Angiocardiography; D035843:Biomedical Research; D001795:Blood Pressure Determination; D002415:Cats; D002533:Cerebral Angiography; D003287:Contrast Media; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D004285:Dogs; D004338:Drug Combinations; D007269:Injections, Intra-Arterial; D012106:Research; D014116:Toxicology; D014567:Urography
D003287:Contrast Media; D004338:Drug Combinations; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; C027278:urovision
ANGIOCARDIOGRAPHY; BLOOD PRESSURE DETERMINATION; CATS; CEREBRAL ANGIOGRAPHY; CLINICAL RESEARCH; CONTRAST MEDIA; DOGS; EXPERIMENTAL LAB STUDY; INJECTIONS, INTRA-ARTERIAL; TOXICOLOGIC REPORT; UROGRAPHY
KLINISCHE PRUEFUNG VON VISOTRAST, EINEM NEUEN TRIJODIERTEN ROENTGENKONTRASTMITTEL VOM AMIDOTRIZOATE-TYP.